Narrative review / 2006
Grapefruit can alter the metabolism of many oral medications, but non-interacting drug alternatives or dietary substitution can prevent adverse interactions.
This review discusses the management of grapefruit-drug interactions. Grapefruit affects the metabolism of medications that undergo extensive intestinal cytochrome P450 3A4 metabolism, have low bioavailability, or possess a narrow therapeutic index, such as statins, antiarrhythmic agents, immunosuppressants, and calcium channel blockers. Management strategies include substituting equally effective alternative drugs that do not interact with grapefruit or excluding grapefruit from the diet and opting for other fruits, including other types of citrus.
- Study type
- Narrative review
- Who was studied
- Patients taking interacting oral medications
- What was measured
- Management of grapefruit-drug interactions
THE PAPER
Management of grapefruit-drug interactions.
Stump AL, Mayo T, Blum A. Am Fam Physician, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.